Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Contact information


christophe.ravaud@dpag.ox.ac.uk


+44 (0)1865 282368


ORCID ID https://orcid.org/0000-0002-0936-851X

Websites

Christophe Ravaud

Postdoctoral Research Scientist

I studied Genetics and Development at University Nice Cote d’Azur, in France where I completed my PhD from 2013 to 2017.

My PhD research was about the side effects of the HAART therapy on the human adipose stem cells, focusing on their self-renewal and differentiation into white and brown adipocytes. After completion my PhD, I moved to Oxford and started to work as a Postdoctoral Research Scientist in Prof. Paul Riley’s group at DPAG and Oxstem, an Oxford spin-out which plans to develop small molecule drugs that can activate repair mechanisms that already exist within the body.

Since May 2020, I have joined an MRC programme in Prof. Paul Riley’s group to study immunomodulation following cardiac injury. More specifically, I am investigating cardiac lymphangiogenesis, which occurs post-myocardial infarction in order to optimise the local injury environment for tissue repair after a heart attack.